ATE175874T1 - 1,4-dihydropyridin-derivate enthaltende tabletten des typs feststoffdispersion und verfahren zu deren herstellung - Google Patents

1,4-dihydropyridin-derivate enthaltende tabletten des typs feststoffdispersion und verfahren zu deren herstellung

Info

Publication number
ATE175874T1
ATE175874T1 AT92109459T AT92109459T ATE175874T1 AT E175874 T1 ATE175874 T1 AT E175874T1 AT 92109459 T AT92109459 T AT 92109459T AT 92109459 T AT92109459 T AT 92109459T AT E175874 T1 ATE175874 T1 AT E175874T1
Authority
AT
Austria
Prior art keywords
solid dispersion
substituted
group
unsubstituted alkyl
tablets
Prior art date
Application number
AT92109459T
Other languages
English (en)
Inventor
Daiichi Watanabe
Hiroko Mimachi
Original Assignee
Fujirebio Kk
Ajinomoto Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujirebio Kk, Ajinomoto Kk filed Critical Fujirebio Kk
Application granted granted Critical
Publication of ATE175874T1 publication Critical patent/ATE175874T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT92109459T 1991-06-05 1992-06-04 1,4-dihydropyridin-derivate enthaltende tabletten des typs feststoffdispersion und verfahren zu deren herstellung ATE175874T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP03134344A JP3110794B2 (ja) 1991-06-05 1991-06-05 １，４−ジヒドロピリジン誘導体を含有する製剤

Publications (1)

Publication Number Publication Date
ATE175874T1 true ATE175874T1 (de) 1999-02-15

Family

ID=15126164

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92109459T ATE175874T1 (de) 1991-06-05 1992-06-04 1,4-dihydropyridin-derivate enthaltende tabletten des typs feststoffdispersion und verfahren zu deren herstellung

Country Status (6)

Country Link
EP (1) EP0521310B1 (de)
JP (1) JP3110794B2 (de)
KR (1) KR100209201B1 (de)
AT (1) ATE175874T1 (de)
DK (1) DK0521310T3 (de)
ES (1) ES2126579T3 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI9300504A (en) * 1993-09-28 1995-04-30 Krka Process for preparation solid dispersions and deposits of calcium antagonist dihidropyrimidine derivates and pharmaceutical compositions comprising the same
CA2346350C (en) 1998-10-05 2008-01-08 Eisai Co., Ltd. Intraoral quickly disintegrating tablets
JP5159012B2 (ja) * 1999-12-23 2013-03-06 メイン・ファ−マ・インタ−ナショナル・プロプライエタリ−・リミテッド 不良溶解性の薬物に対する改良された医薬組成物
BR0109991A (pt) * 2000-04-11 2003-05-27 Sankyo Co Composição farmacêutica
DE10058772A1 (de) * 2000-11-27 2002-06-06 Falk Pharma Gmbh Verfahren zur Herstellung leicht löslicher Arzneimittelformulierungen und entsprechende Formulierungen
KR20040011248A (ko) * 2002-07-30 2004-02-05 환인제약 주식회사 암로디핀의 고체분산체와 그 제조방법 및 그를 포함하는약학적 조성물
US20090304786A1 (en) * 2005-11-25 2009-12-10 Viswaprasad Varanasi Stable Dosage Forms of an Antidepressant
JP5320759B2 (ja) * 2006-04-19 2013-10-23 味の素株式会社 割線錠剤
KR101434316B1 (ko) * 2006-04-19 2014-08-28 아지노모토 가부시키가이샤 고체 분산체의 필름 코팅방법
KR101422052B1 (ko) * 2006-04-19 2014-07-23 아지노모토 가부시키가이샤 할선 정제
JP5828616B2 (ja) * 2007-03-30 2015-12-09 味の素株式会社 固体分散体製剤
CN102415998A (zh) * 2010-09-28 2012-04-18 扬子江药业集团北京海燕药业有限公司 盐酸马尼地平固体分散体及其制备方法
JP2015531749A (ja) 2012-06-21 2015-11-05 メイン ファーマ インターナショナル プロプライエタリー リミテッドＭａｙｎｅ Ｐｈａｒｍａ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｐｔｙ．Ｌｔｄ． イトラコナゾール組成物及び投与剤形、並びにその使用方法
KR20160128449A (ko) * 2012-10-12 2016-11-07 이에이 파마 가부시키가이샤 칼슘 길항약／안지오텐신 ｉｉ 수용체 길항약 함유 의약 제제

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1579818A (en) * 1977-06-07 1980-11-26 Yamanouchi Pharma Co Ltd Nifedipine-containing solid preparation composition
JPS542316A (en) * 1977-06-07 1979-01-09 Yamanouchi Pharmaceut Co Ltd Solid pharmaceutical composition containing nifedipene
JPS58109411A (ja) * 1981-12-23 1983-06-29 Shionogi & Co Ltd ニフエジピン固型製剤組成物
JPS6038322A (ja) * 1983-08-11 1985-02-27 Fujisawa Pharmaceut Co Ltd ジヒドロピリジンａ物質含有易溶性固形製剤
US5028433A (en) * 1988-11-30 1991-07-02 Banyu Pharmaceutical Co., Ltd. Readily absorbable drug formulation of NB-818

Also Published As

Publication number Publication date
EP0521310B1 (de) 1999-01-20
EP0521310A3 (en) 1994-10-05
JP3110794B2 (ja) 2000-11-20
ES2126579T3 (es) 1999-04-01
JPH04360833A (ja) 1992-12-14
KR100209201B1 (ko) 1999-07-15
EP0521310A2 (de) 1993-01-07
DK0521310T3 (da) 1999-09-13

Similar Documents

Publication Publication Date Title
DE3873612D1 (de) Dithioacetal-verbindungen, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
EP0521310A3 (en) Solid dispersion tablets containing 1,4-dihydropyridine derivatives and process for the preparation thereof
ATE185807T1 (de) Thiazolylbenzofuranderivate, verfahren zu deren herstellung und pharmazeutische zusammensetzungen, die sie enthalten
PT88410A (pt) Process for preparing thiazolidinedione derivatives
ATE229017T1 (de) Farnesyltransferase-inhibitoren mit piperidinstruktur und verfahren zu ihrer herstellung
ATE172731T1 (de) Pyrazolopyridinverbindung und verfahren zu ihrer herstellung
ATE13056T1 (de) Indanderivate, verfahren zu ihrer herstellung und sie enthaltende zusammensetzungen.
ATE302778T1 (de) N-substituierte 4-aminopteridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
IE870995L (en) Amino-thiazole and oxazole derivatives
DE69215965D1 (de) Pyrazolopyridinverbindungen und Verfahren zu ihrer Herstellung
DE69004340D1 (de) Substituierte 2-Alkinylphenole mit entzündungshemmender Wirkung, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen.
ATE61340T1 (de) Aminosaeurederivate und deren verfahren zur herstellung.
DE3765827D1 (de) Gegebenenfalls substituierte, 1-(2'-(bis-(phenyl)-methoxy)-aethyl)-4-(3'-(bis-(phenyl)-methoxy)-propyl)-piperazine, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
ATE201024T1 (de) Carbamatderivate von 4-amino-3-isoxazolidinonen und 3-amino-1-hydroxypyrrolidinon-2-onen, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
ES2012507A6 (es) Un procedimiento para la preparacion de derivados de b-lactama.
ATE124408T1 (de) Heterozyklische aminderivate, deren herstellung und deren verwendung.
ES2056860T3 (es) Derivados de n-((2-oxopirrolidin-1-il)-acetil)piperazina y medicamento contra la demencia senil.
ATE159029T1 (de) Phosphonsäurederivate, verfahren zur herstellung und ihre verwendung
ATE48994T1 (de) Benzimidazol-derivat, verfahren zu seiner herstellung und pharmazeutische zusammensetzung.
HUT64318A (en) Process for production benzodpyrane derivativs and pharmaceutical preparations containing these compounds as effective substance
ATE149165T1 (de) Stickstoff enthaltende bizyklische derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
DE69110217D1 (de) Derivate der Kaffeinsäure und sie enthaltende pharmazeutische Zusammensetzungen.
US4351837A (en) 1,4-Dihydropyridine-3,5-dicarboxylate-4-carboxamide compounds, compositions containing same and method of using same
IL87174A (en) Benzimidazole derivatives, their preparation and pharmaceutical compositions containing them
ATE131480T1 (de) Pyrimidoindolderivate und verfahren zu ihrer herstellung

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee